KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Bristol Myers Squibb (BMY) Long-Term Debt Issuances (2017 - 2025)

Bristol Myers Squibb has reported Long-Term Debt Issuances over the past 11 years, most recently at $5.7 billion for Q4 2025.

Quarterly Long-Term Debt Issuances changed N/A to $5.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Dec 2025, down 55.45% year-over-year, with the annual reading at $5.7 billion for FY2025, 55.45% down from the prior year.
Long-Term Debt Issuances was $5.7 billion for Q4 2025 at Bristol Myers Squibb, down from $12.9 billion in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $12.9 billion in Q1 2024 and troughed at $4.5 billion in Q4 2023.
The 4-year median for Long-Term Debt Issuances is $5.8 billion (2022), against an average of $7.3 billion.